Califf Closes In On Reprising His FDA Role After Senate Committee Hearing
Executive Summary
After a mostly friendly round of questioning from members of the US Senate committee on health, the confirmation of President Joe Biden’s pick to lead the US FDA seems more likely.
You may also be interested in...
Califf Clears First Senate Hurdle, But Could FDA’s Abortion Pill Access Decision Be A Headache?
Robert Califf’s nomination to be the next US FDA commissioner squeaked out of the Senate health committee, but a significant number of Republicans are against his confirmation over the agency’s recent decisions on abortion drugs.
Califf Sets Departure From US FDA; Ostroff May Become Interim Leader
As FDA Commissioner Robert Califf prepares to step down from his post to make way for a Trump administration replacement, former Acting Commissioner Stephen Ostroff may step into the breach.
FDA No Longer Publishing Quarterly PMA And HDE Decisions
The US FDA has stopped publishing its list of approvals and denials of premarket approval applications (PMAs) and humanitarian device exemptions (HDEs) in the Federal Register on a quarterly basis. The agency says the change will save money and resources.